UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 10, 2007
COMPUMED, INC. |
(Exact name of registrant as specified in its charter) |
DELAWARE |
| 000-14210 |
| 95-2860434 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
5777 West Century Blvd., Suite 1285, Los Angeles, CA |
| 90045 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant's telephone number, including area code: |
| (310) 258-5000 |
|
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
EXHIBIT NUMBER |
| DESCRIPTION |
|
|
|
| CompuMed to Publish E-Newsletter for Customers and Investors |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CompuMed, Inc. |
| ||
| (Registrant) |
| ||
|
| |||
Date:December 10, 2007 | By: | /s/ Maurizio Vecchione |
| |
|
| Maurizio Vecchione | ||
|
| Interim Chief Executive Officer | ||